K cells: a novel target for insulin gene therapy for the prevention of diabetes.
Recently, gut K cells have been shown to express glucokinase, the glucose sensor of pancreatic beta cells, and transgenic mice expressing human insulin under the control of a K cell-specific promoter are resistant to diabetes development induced by the beta-cell toxin streptozotocin. These novel findings suggest that gut K cells might be a suitable target for gene therapeutic treatment of type 1 diabetes mellitus.